Search for: "Sanofi-Aventis"
Results 61 - 80
of 561
Sort by Relevance
|
Sort by Date
14 Jan 2018, 8:47 am
Andrews in Sanofi-Aventis U.S. [read post]
18 Dec 2017, 5:57 pm
by Dennis Crouch My former bosses Paul Berghoff and Alison Baldwin (at MBHB) won an interesting case today on behalf of Genzyme and its corporate parent Sanofi-Aventis. [read post]
5 Oct 2017, 3:28 pm
Appellants Sanofi, Aventisub LLC, Regeneron PharmaceuticalsInc., and Sanofi-Aventis U.S., LLC (collectively,“Appellants”) appeal from a final judgment of thedistrict court holding U.S. [read post]
5 Sep 2017, 7:45 am
* * * Sanofi-Aventis will receive $38.7 million of federal share of the settlement (DOJ did not describe the federal/state split of the total, making it impossible to compute the percentage share to the relator). [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
29 Mar 2017, 5:15 am
The major impetus behind this suit was Sanofi-Aventis and Regeneron’s discovery that Amgen hired litigation counsel to assert the ‘487 patent and is also working on retaining experts. [read post]
8 Feb 2017, 5:48 am
Taxotere, manufactured by Sanofi-Aventis and sold in the U.S. since 1999, is used to treat patients with advanced or metastasized breast cancer Abilify & Compulsive Gambling Lawsuit Lawyers are investigating lawsuits on behalf of patients who were prescribed the drug Abilify (aripiprazole) and developed compulsive gambling behaviors. [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
6 Jan 2017, 6:04 pm
The FDA found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
6 Jan 2017, 6:04 pm
The FDA found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
30 Nov 2016, 10:58 am
” However, women claim that Sanofi- Aventis breast cancer drug Taxotere has caused them to permanently lose their hair. [read post]
16 Nov 2016, 7:41 am
The manufacturer, Sanofi-Aventis, had different results, claiming that only 3 percent of patients experience permanent hair loss. [read post]
16 Nov 2016, 7:41 am
The manufacturer, Sanofi-Aventis, had different results, claiming that only 3 percent of patients experience permanent hair loss. [read post]
26 Oct 2016, 4:31 am
District Court for the Eastern District of Louisiana against Sanofi-Aventis over the failure to warn about the side effects of Taxotere. [read post]
25 Oct 2016, 11:24 am
District Court for the Eastern District of Louisiana against Sanofi-Aventis over the failure to warn about the side effects of Taxotere. [read post]
